Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Sally Taylor, Selina Tsim, Neal Navani, David Baldwin, Ian Woolhouse, John Edwards, Seamus Grundy, Jonathan Robson, Sarah Rhodes, Nathan Burnside, Fiona Blackhall, Corinne Faivre-Finn, Janelle Yorke, Matthew Evison

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S69
JournalLung Cancer
Publication statusPublished - Mar 2022

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this